Oasmia Pharmaceutical AB Expired Patents
1 granted patents the USPTO lists as expired; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2016-06-02: Application 15101132; Invention Estrogen Receptor Beta Agonists for Use in Treating Mesothelioma; Applicant Oasmia Pharmaceutical AB; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2016-06-02 | 15101132 | Estrogen Receptor Beta Agonists for Use in Treating Mesothelioma | Oasmia Pharmaceutical AB | Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 | 2018-05-22 | 9974776 | US20160303087A1 | Stefan Nilsson Laura Moro Giulia Pinton Arcangela Gabriella Manente | Sweden Italy Italy Italy | HENLEY III, RAYMOND J |